Depósito Digital de Documentos de la UAB Encontrados 3 registros  La búsqueda tardó 0.00 segundos. 
1.
15 p, 2.0 MB Monitoring t-cell responses in translational studies: optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-specific responses / Brinke, Anja ten (Sanquin Research (Amsterdam)) ; Marek-Trzonkowska, Natalia (Medical University of Gdansk. Department of Family Medicine) ; Mansilla Lopez, Maria Jose (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Turksma, Annelies W. (Sanquin Research (Amsterdam)) ; Piekarska, Karolina (Medical University of Gdansk. Department of Family Medicine) ; Iwaszkiewicz-Grzes, Dorota (Medical University of Gdansk. Department of Clinical Immunology and Transplantology) ; Passerini, Laura (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Locafaro, Grazia (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Puñet Ortiz, Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; van Ham, S. Marieke (Sanquin Research (Amsterdam)) ; Hernandez Fuentes, Maria P. (King's College London. MRC Centre for Transplantation) ; Martínez Cáceres, Eva María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gregori, Silvia (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
Adoptive therapy with regulatory T cells or tolerance-inducing antigen (Ag)- presenting cells is innovative and promising therapeutic approach to control undesired and harmful activation of the immune system, as observed in autoimmune diseases, solid organ and bone marrow transplantation. [...]
2017 - 10.3389/fimmu.2017.01870
Frontiers in immunology, Vol. 8 (december 2017) , p. 1-15  
2.
14 p, 516.6 KB Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies / Lord, Phillip (Newcastle University. School of Computing Science) ; Spiering, Rachel (Newcastle University. Institute of Cellular Medicine) ; Aguillon, Juan C. (Universidad de Chile. Instituto de Ciencias Biomédicas (ICBM)) ; Anderson, Amy E. (Newcastle University. Institute of Cellular Medicine) ; Appel, Silke (University of Bergen. Broegelmann Research Laboratory) ; Benítez Ribas, Daniel (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Brinke, Anja ten (Sanquin Research (Amsterdam)) ; Broere, Femke (Utrecht University) ; Cools, Nathalie (University of Antwerp. Vaccine & Infectious Disease Institute) ; Cuturi, Maria Cristina (Center for Research in Transplantation and Immunology (Nantes, França)) ; Diboll, Julie (Newcastle University. Institute of Cellular Medicine) ; Geissler, Edward K. (University Hospital Regensburg. Department of Surgery) ; Giannoukakis, Nick (Institute of Cellular Therapeutics (Pittsburgh, Estats Units d'Amèrica)) ; Gregori, Silvia (San Raffaele Telethon Institute for Gene Therapy (Milà, Itàlia)) ; Ham, S. Marieke van (Sanquin Research (Amsterdam)) ; Lattimer, Staci (Newcastle University. School of Computing Science) ; Marshall, Lindsay (Newcastle University. School of Computing Science) ; Harry, Rachel A. (Newcastle University. Institute of Cellular Medicine) ; Hutchinson, James A. (University Hospital Regensburg. Department of Surgery) ; Isaacs, John D. (Newcastle University. Institute of Cellular Medicine) ; Joosten, Irma (Radboud University Medical Centre) ; Kooten, Cees van (Leiden University Medical Centre) ; López Díaz de Cerio, Ascensión (Clínica Universidad de Navarra) ; Nikolic, Tatjana (Leiden University Medical Centre) ; Oral, Haluk Barbaros (Uludag University. Faculty of Medicine) ; Sofronic Milosavljevic, Ljiljana (University of Belgrade. Institute for the Application of Nuclear Energy) ; Ritter, Thomas (National University of Ireland) ; Riquelme, Paloma (University Hospital Regensburg. Department of Surgery) ; Thomson, Angus W. (University of Pittsburgh School of Medicine) ; Trucco, Massimo (Institute of Cellular Therapeutics (Pittsburgh, Estats Units d'Amèrica)) ; Vives Pi, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez Cáceres, Eva María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hilkens, Catharien M. U. (Newcastle University. Institute of Cellular Medicine)
Cellular therapies with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation. [...]
2016 - 10.7717/peerj.2300
PeerJ, Vol. 4 (August 2016) , p. e2300  
3.
9 p, 1.4 MB Clinical use of tolerogenic dendritic cells-harmonization approach in european collaborative effort / Brinke, Anja ten (Sanquin Blood Supply (Amsterdam)) ; Hilkens, Catharien M. U. (Newcastle University. Institute of Cellular Medicine) ; Cools, Nathalie (University of Antwerp. Vaccine & Infectious Disease Institute) ; Geissler, Edward K. (University Hospital Regensburg. Department of Surgery) ; Hutchinson, James A. (University Hospital Regensburg. Department of Surgery) ; Lombardi, Giovanna (King's College London. MRC Centre for Transplantation) ; Lord, Phillip (Newcastle University. School of Computing Science) ; Sawitzki, Birgit (Charité - Universitätsmedizin Berlin) ; Trzonkowski, Piotr (Medical University of Gdansk. Department of Clinical Immunology and Transplantology) ; Ham, S. Marieke van (Sanquin Blood Supply (Amsterdam)) ; Martínez Cáceres, Eva María (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
The number of patients with autoimmune diseases and severe allergies and recipients of transplants increases worldwide. Currently, these patients require lifelong administration of immunomodulatory drugs. [...]
2015 - 10.1155/2015/471719
Mediators of Inflammation, 2015, Article ID 471719  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.